ASX - By Stock
|
RCE |
Re:
Ann: Phase I/II UTI/Urosepsis Rapid Infusion Trial Complete
|
|
bigwilllly
|
72 |
19K |
3 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
72
|
19K
|
3
|
|
ASX - By Stock
|
RCE |
Re:
General Discussion Recce
|
|
bigwilllly
|
2 |
599 |
5 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
2
|
599
|
5
|
|
ASX - By Stock
|
RCE |
Re:
General Discussion Recce
|
|
bigwilllly
|
2 |
599 |
1 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
2
|
599
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: R327 Efficacy against WHO Priority Pathogen Acinetobacter B
|
|
bigwilllly
|
19 |
5.7K |
3 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
19
|
5.7K
|
3
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Phase I/II UTI/Urosepsis Rapid Infusion Trial Complete
|
|
bigwilllly
|
72 |
19K |
2 |
05/07/24 |
05/07/24 |
ASX - By Stock
|
72
|
19K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Placement & SPP to raise $10 million - Funded to FY26
|
|
bigwilllly
|
17 |
5.7K |
1 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
17
|
5.7K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Phase I/II UTI/Urosepsis Rapid Infusion Trial Complete
|
|
bigwilllly
|
72 |
19K |
2 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
72
|
19K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Trading Halt
|
|
bigwilllly
|
20 |
5.5K |
3 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
20
|
5.5K
|
3
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Phase I/II UTI/Urosepsis Rapid Infusion Trial Complete
|
|
bigwilllly
|
72 |
19K |
1 |
30/06/24 |
30/06/24 |
ASX - By Stock
|
72
|
19K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Phase I/II UTI/Urosepsis Rapid Infusion Trial Complete
|
|
bigwilllly
|
72 |
19K |
2 |
29/06/24 |
29/06/24 |
ASX - By Stock
|
72
|
19K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Phase I/II UTI/Urosepsis Rapid Infusion Trial Complete
|
|
bigwilllly
|
72 |
19K |
0 |
28/06/24 |
28/06/24 |
ASX - By Stock
|
72
|
19K
|
0
|
|
ASX - By Stock
|
RCE |
Re:
Ann: R327 added to WHO List of Antibacterial Products
|
|
bigwilllly
|
25 |
8.2K |
2 |
27/06/24 |
27/06/24 |
ASX - By Stock
|
25
|
8.2K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Ethics Approval Broadens to All Topical Infections
|
|
bigwilllly
|
17 |
4.5K |
4 |
26/06/24 |
26/06/24 |
ASX - By Stock
|
17
|
4.5K
|
4
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Ethics Approval Broadens to All Topical Infections
|
|
bigwilllly
|
17 |
4.5K |
3 |
26/06/24 |
26/06/24 |
ASX - By Stock
|
17
|
4.5K
|
3
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Cohort Dosing Complete Ph I/II UTI/Urosepsis Clinical Trial
|
|
bigwilllly
|
48 |
16K |
2 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
48
|
16K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Cohort Dosing Complete Ph I/II UTI/Urosepsis Clinical Trial
|
|
bigwilllly
|
48 |
16K |
1 |
16/03/24 |
16/03/24 |
ASX - By Stock
|
48
|
16K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Cohort Dosing Complete Ph I/II UTI/Urosepsis Clinical Trial
|
|
bigwilllly
|
48 |
16K |
2 |
16/03/24 |
16/03/24 |
ASX - By Stock
|
48
|
16K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Next Cohort Dosing Ph I/II UTI/Urosepsis Clinical Trial
|
|
bigwilllly
|
39 |
9.4K |
1 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
39
|
9.4K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Next Cohort Dosing Ph I/II UTI/Urosepsis Clinical Trial
|
|
bigwilllly
|
39 |
9.4K |
0 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
39
|
9.4K
|
0
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Next Cohort Dosing Ph I/II UTI/Urosepsis Clinical Trial
|
|
bigwilllly
|
39 |
9.4K |
0 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
39
|
9.4K
|
0
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Next Cohort Dosing Ph I/II UTI/Urosepsis Clinical Trial
|
|
bigwilllly
|
39 |
9.4K |
0 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
39
|
9.4K
|
0
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Next Cohort Dosing Ph I/II UTI/Urosepsis Clinical Trial
|
|
bigwilllly
|
39 |
9.4K |
1 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
39
|
9.4K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Next Cohort Dosing Ph I/II UTI/Urosepsis Clinical Trial
|
|
bigwilllly
|
39 |
9.4K |
1 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
39
|
9.4K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Next Cohort Dosing Ph I/II UTI/Urosepsis Clinical Trial
|
|
bigwilllly
|
39 |
9.4K |
3 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
39
|
9.4K
|
3
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Next Cohort Dosing Ph I/II UTI/Urosepsis Clinical Trial
|
|
bigwilllly
|
39 |
9.4K |
1 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
39
|
9.4K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Next Cohort Dosing Ph I/II UTI/Urosepsis Clinical Trial
|
|
bigwilllly
|
39 |
9.4K |
5 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
39
|
9.4K
|
5
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Receives AUD $11.17m R&D Advance
|
|
bigwilllly
|
38 |
12K |
2 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
38
|
12K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Continues Strategic Partnership with MCRI
|
|
bigwilllly
|
53 |
15K |
1 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
53
|
15K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Continues Strategic Partnership with MCRI
|
|
bigwilllly
|
53 |
15K |
1 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
53
|
15K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Continues Strategic Partnership with MCRI
|
|
bigwilllly
|
53 |
15K |
1 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
53
|
15K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Receives AUD $11.17m R&D Advance
|
|
bigwilllly
|
38 |
12K |
3 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
38
|
12K
|
3
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Continues Strategic Partnership with MCRI
|
|
bigwilllly
|
53 |
15K |
1 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
53
|
15K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Continues Strategic Partnership with MCRI
|
|
bigwilllly
|
53 |
15K |
3 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
53
|
15K
|
3
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Continues Strategic Partnership with MCRI
|
|
bigwilllly
|
53 |
15K |
1 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
53
|
15K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Continues Strategic Partnership with MCRI
|
|
bigwilllly
|
53 |
15K |
0 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
53
|
15K
|
0
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Continues Strategic Partnership with MCRI
|
|
bigwilllly
|
53 |
15K |
1 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
53
|
15K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Continues Strategic Partnership with MCRI
|
|
bigwilllly
|
53 |
15K |
0 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
53
|
15K
|
0
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Continues Strategic Partnership with MCRI
|
|
bigwilllly
|
53 |
15K |
0 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
53
|
15K
|
0
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Continues Strategic Partnership with MCRI
|
|
bigwilllly
|
53 |
15K |
0 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
53
|
15K
|
0
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Continues Strategic Partnership with MCRI
|
|
bigwilllly
|
53 |
15K |
0 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
53
|
15K
|
0
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Continues Strategic Partnership with MCRI
|
|
bigwilllly
|
53 |
15K |
0 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
53
|
15K
|
0
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Continues Strategic Partnership with MCRI
|
|
bigwilllly
|
53 |
15K |
0 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
53
|
15K
|
0
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Continues Strategic Partnership with MCRI
|
|
bigwilllly
|
53 |
15K |
0 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
53
|
15K
|
0
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Continues Strategic Partnership with MCRI
|
|
bigwilllly
|
53 |
15K |
0 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
53
|
15K
|
0
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Continues Strategic Partnership with MCRI
|
|
bigwilllly
|
53 |
15K |
1 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
53
|
15K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Continues Strategic Partnership with MCRI
|
|
bigwilllly
|
53 |
15K |
1 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
53
|
15K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Continues Strategic Partnership with MCRI
|
|
bigwilllly
|
53 |
15K |
1 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
53
|
15K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Continues Strategic Partnership with MCRI
|
|
bigwilllly
|
53 |
15K |
1 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
53
|
15K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Continues Strategic Partnership with MCRI
|
|
bigwilllly
|
53 |
15K |
0 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
53
|
15K
|
0
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Continues Strategic Partnership with MCRI
|
|
bigwilllly
|
53 |
15K |
3 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
53
|
15K
|
3
|
|